Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Kidney Transplantation

Free Subscription Articles published in J Am Soc Nephrol Retrieve available abstracts of 58 articles: HTML format

Single Articles

May 2026
1. YEUNG WONG ET, Balshaw R, Gibson IW, Ho J, et al
   Microvascular Inflammation in Kidney Transplantation.
   J Am Soc Nephrol. 2026 May 7. doi: 10.1681/ASN.0000001125.
   PubMed     Abstract available
   
   
   
2. LAM NN, Caliskan Y, Husain SA, Lentine KL, et al
   Evaluation and Counseling of Living Kidney Donor Candidates.
   J Am Soc Nephrol. 2026;37:1069-1077.
   PubMed     Abstract available
   
   
   
3. YU ASL, Cohen A, Torres VE, Chebib FT, et al
   Development and Validation of a Multivariable Prediction Model for Kidney Failure in Early Autosomal Dominant Polycystic Kidney Disease.
   J Am Soc Nephrol. 2026;37:1010-1021.
   PubMed     Abstract available
   
   
   April 2026
4. PIEDRAFITA A, Sablik M, Preka E, Goutaudier V, et al
   Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation.
   J Am Soc Nephrol. 2026 Apr 23. doi: 10.1681/ASN.0000001107.
   PubMed     Abstract available
   
   
   
5. TANGRI N, Cheungpasitporn W, Crittenden SD, Fornoni A, et al
   Responsible Use of Artificial Intelligence to Improve Kidney Care: A Statement from the American Society of Nephrology.
   J Am Soc Nephrol. 2026;37:881-890.
   PubMed     Abstract available
   
   
   
6. ISRANI A, Sandorffy BL, Liu CS, Fraticelli Ortiz DI, et al
   Class 1 Indications for Coronary Revascularization Identified in Prekidney Transplant Screening.
   J Am Soc Nephrol. 2026;37:801-813.
   PubMed     Abstract available
   
   
   February 2026
7. GUPTA M, Cheng XS
   Rethinking Routine Coronary Screening in Kidney Transplant Candidates.
   J Am Soc Nephrol. 2026 Feb 27. doi: 10.1681/ASN.0000001042.
   PubMed    
   
   
   
8. SHI B, Bleasel JM, Ying T, Chadban SJ, et al
   Design and Reporting Quality of Noninferiority Trials in Kidney Transplantation: A Systematic Review.
   J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001041.
   PubMed     Abstract available
   
   
   December 2025
9. CHAPMAN GB, Dhaun N
   Cardiovascular Risk Assessment in Kidney Transplantation: Are We Asking the Right Questions?
   J Am Soc Nephrol. 2025 Dec 23. doi: 10.1681/ASN.0000000987.
   PubMed    
   
   
   
10. CHEN G, Wang Z
    Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000973.
    PubMed    
    
    
    
11. ADEYEMO S, Crews DC, Lentine KL, Al Ammary F, et al
    Authors' Reply: Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000974.
    PubMed    
    
    
    
12. HUSAIN SA, Neil D, Sharif A, Naesens M, et al
    Preimplantation Histopathologic Assessment of Deceased Donor Kidneys: Recommendations from the Banff Time-Zero Biopsy Working Group.
    J Am Soc Nephrol. 2025;36:2505-2513.
    PubMed     Abstract available
    
    
    
13. KUCIRKA LM, Boggess KA, Wood ME, Quist-Nelson J, et al
    Severe Maternal Morbidity and Long-Term Kidney Outcomes among Pregnant Women Receiving Maintenance Dialysis.
    J Am Soc Nephrol. 2025 Dec 1. doi: 10.1681/ASN.0000000949.
    PubMed    
    
    
    November 2025
14. BRENNAN DC
    Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE Study.
    J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000939.
    PubMed    
    
    
    
15. SANDERS JF, de Boer SE, Jonker J, Bemelman FJ, et al
    Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000924.
    PubMed    
    
    
    
16. CARDOSO DE AGUIAR R, Willicombe M, Roufosse C
    Noninvasive Diagnosis of Kidney Allograft Rejection.
    J Am Soc Nephrol. 2025;36:2269-2285.
    PubMed     Abstract available
    
    
    
17. GOUTAUDIER V, Aubert O, Racape M, Truchot A, et al
    Detection of Kidney Allograft Rejection Using Urinary Chemokines.
    J Am Soc Nephrol. 2025;36:2228-2240.
    PubMed     Abstract available
    
    
    October 2025
18. TATAPUDI VS, Mattoo A, Schiff T, Mehta SA, et al
    Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated Injury.
    J Am Soc Nephrol. 2025;36:2030-2040.
    PubMed     Abstract available
    
    
    September 2025
19. ADEYEMO S, Crews DC, Lentine KL, Zisman-Ilani Y, et al
    Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009-2024.
    J Am Soc Nephrol. 2025 Sep 16. doi: 10.1681/ASN.0000000876.
    PubMed     Abstract available
    
    
    
20. EBRAHIMI N, Wongworawat YC, Pour AA, Norouzi S, et al
    Correction to: Kidney Week 2024 Abstract Treatment of Recurrent IgA Nephropathy after Kidney Transplant with Delayed-Release Budesonide TH-PO709.
    J Am Soc Nephrol. 2025 Sep 10. doi: 10.1681/ASN.0000000892.
    PubMed    
    
    
    July 2025
21. CHRISTOU CD, Jaradat F, Olsburgh J, Sacks S, et al
    Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000826.
    PubMed     Abstract available
    
    
    May 2025
22. PERKINS GB, Tunbridge MJ, Chai CS, Hope CM, et al
    mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2025 May 22. doi: 10.1681/ASN.0000000716.
    PubMed     Abstract available
    
    
    
23. SCHOLD JD, Arrigain S, Husain SA, Yu M, et al
    Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States.
    J Am Soc Nephrol. 2025 May 6. doi: 10.1681/ASN.0000000734.
    PubMed     Abstract available
    
    
    
24. JAVA A, Sparks MA, Kavanagh D
    Post-transplant Thrombotic Microangiopathy.
    J Am Soc Nephrol. 2025;36:940-951.
    PubMed     Abstract available
    
    
    April 2025
25. VINSON AJ, Matas A
    Late Allograft Loss and Contemporary Cardiorenal Metabolic Therapies.
    J Am Soc Nephrol. 2025;36:1659-1667.
    PubMed     Abstract available
    
    
    
26. TRUCHOT A, Raynaud M, Helantera I, Aubert O, et al
    Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.
    J Am Soc Nephrol. 2025;36:688-701.
    PubMed     Abstract available
    
    
    March 2025
27. TELLEZ GARCIA JM, Steenvoorden T, Bemelman F, Hilhorst M, et al
    The Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney Transplantation.
    J Am Soc Nephrol. 2025 Mar 28. doi: 10.1681/ASN.0000000711.
    PubMed     Abstract available
    
    
    February 2025
28. ADLER JT, Kuk AE, Drewry KM, Nguyen KH, et al
    Implications of Increased Medicare Advantage Enrollment for Access to Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Feb 20. doi: 10.1681/ASN.0000000667.
    PubMed    
    
    
    November 2024
29. TANGIRALA N, Hewawasam E, Davies CE, Poprzeczny A, et al
    Labor and Delivery Outcomes in Australian Mothers after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Nov 25. doi: 10.1681/ASN.0000000559.
    PubMed    
    
    
    October 2024
30. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024;35:1425-1433.
    PubMed     Abstract available
    
    
    September 2024
31. WILHELM M, Geng A, Schaub S, Hirsch HH, et al
    Posoleucel for BK Polyomavirus in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Sep 20. doi: 10.1681/ASN.0000000000000500.
    PubMed    
    
    
    
32. KIMMEL PL, Fwu CW, Nolin TD, Schulman IH, et al
    Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020.
    J Am Soc Nephrol. 2024 Sep 3. doi: 10.1681/ASN.0000000000000478.
    PubMed     Abstract available
    
    
    
33. PERCUDANI R, Capelli C, Sassi G, Mori G, et al
    Evolutionary Differences in Uric Acid Metabolism Inform about the Risks of Pig-to-Human Kidney Transplant.
    J Am Soc Nephrol. 2024;35:1281-1283.
    PubMed    
    
    
    August 2024
34. CHAO CT
    The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000482.
    PubMed    
    
    
    
35. GUPTA A
    Authors' Reply: The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000483.
    PubMed    
    
    
    
36. MANNON RB, Vincenti F
    Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 5. doi: 10.1681/ASN.0000000000000475.
    PubMed    
    
    
    
37. AL AMMARY F, Adeyemo S, Lentine KL, Muzaale AD, et al
    Evolution of Biologically Related Living Kidney Donation in the United States from 1988 to 2022.
    J Am Soc Nephrol. 2024;35:1104-1106.
    PubMed    
    
    
    
38. KNOERS NVAM, van Eerde AM
    The Role of Genetic Testing in Adult CKD.
    J Am Soc Nephrol. 2024;35:1107-1118.
    PubMed     Abstract available
    
    
    July 2024
39. PAJEWSKI NM, Beddhu S, Bress AP, Chang TI, et al
    The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 30. doi: 10.1681/ASN.0000000000000459.
    PubMed     Abstract available
    
    
    
40. GUPTA A, Holloway P, Young K, Villwock J, et al
    Changes in Olfactory and Cognitive Function after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000456.
    PubMed    
    
    
    
41. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000457.
    PubMed     Abstract available
    
    
    
42. PATZER RE
    Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?
    J Am Soc Nephrol. 2024;35:959-961.
    PubMed    
    
    
    May 2024
43. STOCK P, Rickert CG
    Consent for High-Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right.
    J Am Soc Nephrol. 2024;35:528-529.
    PubMed    
    
    
    
44. SCHOLD JD, Conzen KD, Cooper J, Arrigain S, et al
    Quantifying the Effect of Consent for High-Kidney Donor Profile Index Deceased Donor Transplants in the United States.
    J Am Soc Nephrol. 2024;35:630-641.
    PubMed    
    
    
    
45. KING KL, Yu M, Huml AM, Schold JD, et al
    Allocation and Utilization Patterns of Deceased Donor Kidneys for Preemptive Transplantation in the United States.
    J Am Soc Nephrol. 2024;35:642-645.
    PubMed    
    
    
    April 2024
46. VAULET T, Callemeyn J, Lamarthee B, Antoranz A, et al
    The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.
    J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000350.
    PubMed     Abstract available
    
    
    
47. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    PubMed    
    
    
    March 2024
48. CHANDRAKER A, Regmi A, Gohh R, Sharma A, et al
    Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    J Am Soc Nephrol. 2024 Mar 12. doi: 10.1681/ASN.0000000000000329.
    PubMed     Abstract available
    
    
    
49. LAN JH
    Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape.
    J Am Soc Nephrol. 2024;35:259-260.
    PubMed    
    
    
    January 2024
50. ADLER JT, Kuk AE, Cron DC, Parast L, et al
    Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
    J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
    PubMed    
    
    
    
51. BAE S, McAdams-DeMarco MA
    Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:130.
    PubMed    
    
    
    
52. LI Y, Luo F, Gao Q, Su L, et al
    Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:129.
    PubMed    
    
    
    December 2023
53. VINCENTI F, Bestard O, Brar A, Cruzado JM, et al
    Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
    J Am Soc Nephrol. 2023 Dec 26. doi: 10.1681/ASN.0000000000000287.
    PubMed     Abstract available
    
    
    
54. HUSAIN SA
    Recentering Accountability for Disparities in Kidney Transplant Access.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
    PubMed    
    
    
    
55. RAYNAUD M, Al-Awadhi S, Louis K, Zhang H, et al
    Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal.
    J Am Soc Nephrol. 2023 Dec 6. doi: 10.1681/ASN.0000000000000260.
    PubMed     Abstract available
    
    
    
56. RIZZOLO K, Cervantes L, Wilhalme H, Vasilyev A, et al
    Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure.
    J Am Soc Nephrol. 2023;34:2013-2023.
    PubMed     Abstract available
    
    
    October 2023
57. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
    Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
    J Am Soc Nephrol. 2023;34:1615-1617.
    PubMed    
    
    
    
58. GREGORY AV, Denic A, Moustafa A, Dasaraju PG, et al
    The Number and Size of Individual Kidney Medullary Pyramids is Associated with Clinical Characteristics, Kidney Biopsy Findings, and CKD Outcomes among Kidney Donors.
    J Am Soc Nephrol. 2023;34:1752-1763.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum